In conclusion, our data reveal that ZEB2‐AS1 is highly expressed in a fraction of HNSCC and its overexpression significantly associates with tumour aggressiveness and unfavourable prognosis. This evidence concerns the gene ZEB2 and head and neck squamous cell carcinoma.